The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes.
The prevalence of non-alcoholic fatty-liver disease (NAFLD) is increasing globally. NAFLD is a spectrum of related liver diseases that progressive from simple steatosis to serious complications like cirrhosis. The major pathophysiological driving of NAFLD includes elevated hepatic adiposity, increas...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c166a91c05ff447c8376536f3176defd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c166a91c05ff447c8376536f3176defd |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c166a91c05ff447c8376536f3176defd2021-11-18T08:46:10ZThe heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes.1932-620310.1371/journal.pone.0079270https://doaj.org/article/c166a91c05ff447c8376536f3176defd2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24260182/?tool=EBIhttps://doaj.org/toc/1932-6203The prevalence of non-alcoholic fatty-liver disease (NAFLD) is increasing globally. NAFLD is a spectrum of related liver diseases that progressive from simple steatosis to serious complications like cirrhosis. The major pathophysiological driving of NAFLD includes elevated hepatic adiposity, increased hepatic triglycerides/cholesterol, excessive hepatic inflammation, and hepatocyte ballooning injury is a common histo-pathological denominator. Although heme-oxygenase (HO) is cytoprotective, its effects on hepatocyte ballooning injury have not been reported. We investigated the effects of upregulating HO with hemin or inhibiting it with stannous-mesoporphyrin (SnMP) on hepatocyte ballooning injury, hepatic adiposity and inflammation in Zucker-diabetic-fatty rats (ZDFs), an obese type-2-diabetic model. Hemin administration to ZDFs abated hepatic/plasma triglycerides and cholesterol, and suppressed several pro-inflammatory cytokines and chemokines including, TNF-α, IL-6, IL-1β, macrophage-inflammatory-protein-1α (MIP-1α) and macrophage-chemoattractant-protein-1 (MCP-1), with corresponding reduction of the pro-inflammatory M1-phenotype marker, ED1 and hepatic macrophage infiltration. Correspondingly, hemin concomitantly potentiated the protein expression of several markers of the anti-inflammatory macrophage-M2-phenotype including ED2, IL-10 and CD-206, alongside components of the HO-system including HO-1, HO-activity and cGMP, whereas the HO-inhibitor, SnMP abolished the effects. Furthermore, hemin attenuated liver histo-pathological lesions like hepatocyte ballooning injury and fibrosis, and reduced extracellular-matrix/profibrotic proteins implicated in liver injury such as osteopontin, TGF-β1, fibronectin and collagen-IV. We conclude that hemin restore hepatic morphology by abating hepatic adiposity, suppressing macrophage infiltration, inflammation and fibrosis. The selective enhancement of anti-inflammatory macrophage-M2-phenotype with parallel reduction of pro-inflammatory macrophage-M1-phenotype and related chemokines/cytokines like TNF-α, IL-6, IL-1β, MIP-1α and MCP-1 are among the multifaceted mechanisms by which hemin restore hepatic morphology.Tatiana Ntube SalleyManish MishraShuchita TiwariAshok JadhavJoseph Fomusi NdisangPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 11, p e79270 (2013) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Tatiana Ntube Salley Manish Mishra Shuchita Tiwari Ashok Jadhav Joseph Fomusi Ndisang The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes. |
description |
The prevalence of non-alcoholic fatty-liver disease (NAFLD) is increasing globally. NAFLD is a spectrum of related liver diseases that progressive from simple steatosis to serious complications like cirrhosis. The major pathophysiological driving of NAFLD includes elevated hepatic adiposity, increased hepatic triglycerides/cholesterol, excessive hepatic inflammation, and hepatocyte ballooning injury is a common histo-pathological denominator. Although heme-oxygenase (HO) is cytoprotective, its effects on hepatocyte ballooning injury have not been reported. We investigated the effects of upregulating HO with hemin or inhibiting it with stannous-mesoporphyrin (SnMP) on hepatocyte ballooning injury, hepatic adiposity and inflammation in Zucker-diabetic-fatty rats (ZDFs), an obese type-2-diabetic model. Hemin administration to ZDFs abated hepatic/plasma triglycerides and cholesterol, and suppressed several pro-inflammatory cytokines and chemokines including, TNF-α, IL-6, IL-1β, macrophage-inflammatory-protein-1α (MIP-1α) and macrophage-chemoattractant-protein-1 (MCP-1), with corresponding reduction of the pro-inflammatory M1-phenotype marker, ED1 and hepatic macrophage infiltration. Correspondingly, hemin concomitantly potentiated the protein expression of several markers of the anti-inflammatory macrophage-M2-phenotype including ED2, IL-10 and CD-206, alongside components of the HO-system including HO-1, HO-activity and cGMP, whereas the HO-inhibitor, SnMP abolished the effects. Furthermore, hemin attenuated liver histo-pathological lesions like hepatocyte ballooning injury and fibrosis, and reduced extracellular-matrix/profibrotic proteins implicated in liver injury such as osteopontin, TGF-β1, fibronectin and collagen-IV. We conclude that hemin restore hepatic morphology by abating hepatic adiposity, suppressing macrophage infiltration, inflammation and fibrosis. The selective enhancement of anti-inflammatory macrophage-M2-phenotype with parallel reduction of pro-inflammatory macrophage-M1-phenotype and related chemokines/cytokines like TNF-α, IL-6, IL-1β, MIP-1α and MCP-1 are among the multifaceted mechanisms by which hemin restore hepatic morphology. |
format |
article |
author |
Tatiana Ntube Salley Manish Mishra Shuchita Tiwari Ashok Jadhav Joseph Fomusi Ndisang |
author_facet |
Tatiana Ntube Salley Manish Mishra Shuchita Tiwari Ashok Jadhav Joseph Fomusi Ndisang |
author_sort |
Tatiana Ntube Salley |
title |
The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes. |
title_short |
The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes. |
title_full |
The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes. |
title_fullStr |
The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes. |
title_full_unstemmed |
The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes. |
title_sort |
heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2013 |
url |
https://doaj.org/article/c166a91c05ff447c8376536f3176defd |
work_keys_str_mv |
AT tatianantubesalley thehemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes AT manishmishra thehemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes AT shuchitatiwari thehemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes AT ashokjadhav thehemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes AT josephfomusindisang thehemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes AT tatianantubesalley hemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes AT manishmishra hemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes AT shuchitatiwari hemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes AT ashokjadhav hemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes AT josephfomusindisang hemeoxygenasesystemrescueshepaticdeteriorationintheconditionofobesitycomorbidwithtype2diabetes |
_version_ |
1718421347411951616 |